SCHEMBL23784367

SCHEMBL23784367

COc1cc2c(cc1OCCCN1CCCC1)[nH]c1cc(C)ncc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EHMT2 Q96KQ7 9/20 0.52
▸ EHMT1 Q9H9B1 6/20 0.52
▸ SPIN1 Q9Y657 3/20 0.50
▸ KIT P10721 2/20 0.49
▸ PLK4 O00444 1/20 0.49
▸ GAK O14976 1/20 0.49
▸ EPHB6 O15197 1/20 0.49
▸ RIPK2 O43353 1/20 0.49
▸ ERN1 O75460 1/20 0.49
▸ STK10 O94804 1/20 0.49
▸ MAP4K4 O95819 1/20 0.49
▸ CHEK2 O96017 1/20 0.49
▸ ABL1 P00519 1/20 0.49
▸ EGFR P00533 1/20 0.49
▸ ERBB2 P04626 1/20 0.49
▸ LCK P06239 1/20 0.49
▸ FYN P06241 1/20 0.49
▸ CSF1R P07333 1/20 0.49
▸ YES1 P07947 1/20 0.49
▸ LYN P07948 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20581101 0.99 EHMT2 (0.51) EHMT2EHMT1SPIN1KITPLK4
SCHEMBL23784378 0.88 EHMT2 (0.51) EHMT2EHMT1SPIN1KITPLK4
SCHEMBL20581138 0.88 EHMT2 (0.56) EHMT2EHMT1SPIN1KITPLK4
Hydrochloric Acid SCHEMBL20581141 0.87 EHMT2 (0.55) EHMT2EHMT1SPIN1TLR9TLR7
SCHEMBL23784349 0.86 EHMT2 (0.49) EHMT2EHMT1SPIN1KITPLK4
SCHEMBL23784377 0.85 SPIN1 (0.51) EHMT2EHMT1SPIN1DNMT1TLR9
SCHEMBL20581185 0.85 KDM4E (0.40) EHMT2EHMT1SPIN1KITPLK4
SCHEMBL20580883 0.85 EHMT2 (0.55) EHMT2EHMT1SPIN1KITPLK4
Hydrochloric Acid SCHEMBL20581331 0.84 SPIN1 (0.51) EHMT2EHMT1SPIN1DNMT1TLR9
SCHEMBL23784351 0.84 EHMT2 (0.51) EHMT2EHMT1SPIN1KITPLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3634962-B1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS INC (US) 2023-05-24 — — EP disclosed
US-20210371417-A1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. 2021-12-02 — — US disclosed
US-11111243-B2 Azaindole compounds as histone methyltransferase inhibitors GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11111243-B2 Azaindole compounds as histone methyltransferase inhibitors EHMT2, EHMT1, EZH2 EHMT2 1/4885EHMT1 2/4885SPIN1 294/4885
US-20210371417-A1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS EHMT2, EHMT1, EZH2 EHMT2 1/4885EHMT1 2/4885SPIN1 294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback